×
About 66,502 results

ALLMedicine™ Inflammatory Bowel Disease Center

Research & Reviews  31,609 results

De Novo Inflammatory Bowel Disease Rarely Occurs During Posttransplant Immunosuppression.
https://doi.org/10.1093/ajcp/aqab084
American Journal of Clinical Pathology; Fang JM, Lamps L et. al.

Jun 14th, 2021 - De novo chronic idiopathic inflammatory bowel disease (CIIBD) is reported to occur at higher rates in posttransplant patients than that of the general population. The previous reports, however, included patients with primary sclerosing cholangitis...

Understanding the surgical experience for Black and White patients with inflammatory bo...
https://doi.org/10.1016/j.amjsurg.2021.06.003
American Journal of Surgery; Dos Santos Marques IC, Herbey II et. al.

Jun 13th, 2021 - Racial/ethnic disparities in outcomes exist for patients with inflammatory bowel disease (IBD) undergoing surgery. The underlying mechanism(s) remain unclear and patient perspectives are needed. We therefore aimed to characterize the surgical expe...

Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous cli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692083
Autoimmunity Reviews; Both T, Dalm VASH et. al.

Jun 12th, 2021 - The analysis of time-varying activity and connectivity patterns (i.e., the chronnectome) using resting-state magnetic resonance imaging has become an important part of ongoing neuroscience discussions. The majority of previous work has focused on ...

The Splanchnic Reservoir: An Oasis for Blood Volume in Heart Failure with Preserved Eje...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109966
European Journal of Heart Failure; Patel RB, Shah SJ

Jun 12th, 2021 - Pyoderma gangrenosum is a rare non-infectious skin disorder. It is often associated with systemic diseases, like the inflammatory bowel disease, rheumatological disease and (hematological) malignancy. The diagnosis is affirmed through a process of...

Amyloid-β: a potential link between epilepsy and cognitive decline.
https://doi.org/10.1038/s41582-021-00505-9 10.1016/S1474-4422(18)30256-4 10.1016/S1474-4422(18)30403-4 10.1016/S0140-6736(20)30750-9 10.1016/S1474-4422(16)30356-8 10.1016/S0197-4580(97)00056-0 10.1038/nrdp.2015.56 10.1093/brain/awz268 10.1038/nrneurol.2017.162 10.1016/S1474-4422(12)70291-0 10.1001/jamaneurol.2013.5847 10.1523/JNEUROSCI.5215-08.2009 10.1016/j.neurobiolaging.2016.08.025 10.1001/jamaneurol.2020.0187 10.1038/nrn.2016.141 10.3389/fneur.2020.00199 10.3233/JAD-150544 10.1016/j.neurobiolaging.2018.09.006 10.1016/S0140-6736(19)33064-8 10.3233/JAD-150096 10.1093/brain/awy022 10.1002/ca.980080612 10.1038/nature20814 10.1126/science.1566067 10.1016/j.braindev.2004.07.008 10.1016/S1474-4422(17)30044-3 10.1038/s41583-019-0240-3 10.1001/jamaneurol.2018.0629 10.1038/nn.2583 10.1016/0896-6273(95)90107-8 10.1016/S0896-6273(03)00787-6 10.1523/JNEUROSCI.0277-04.2004 10.1093/hmg/ddh019 10.1016/j.neuron.2007.07.025 10.1001/archneurol.2009.15 10.1186/s13024-017-0231-7 10.1523/JNEUROSCI.5171-13.2014 10.3389/fneur.2019.01151 10.1016/j.neurobiolaging.2018.07.009 10.1126/science.1162844 10.1016/j.brainres.2017.09.026 10.1073/pnas.1206171109 10.1038/nm1782 10.1523/JNEUROSCI.5825-09.2010 10.1101/cshperspect.a024075 10.1093/brain/awv355 10.1038/nn.2433 10.1016/j.neurobiolaging.2006.06.019 10.2174/1567205013666160129095508 10.1016/j.brainres.2010.07.061 10.1126/science.aay0198 10.1146/annurev-neuro-080317-061725 10.3233/JAD-2011-091717 10.1016/j.nbd.2015.10.019 10.1002/hipo.23129 10.1038/nn.2709 10.1038/srep20119 10.1073/pnas.0600948103 10.1101/801902 10.1016/j.neuron.2020.06.005 10.1016/S0896-6273(03)00124-7 10.3892/mmr.2014.1977 10.1126/science.1141736 10.1038/s41593-018-0289-8 10.1038/s41593-020-0687-6 10.1186/s13024-020-00393-5 10.1016/j.neuron.2012.03.023 10.1016/j.yebeh.2019.106478 10.1515/revneuro-2017-0064 10.1016/j.neuroscience.2014.11.051 10.3389/fnagi.2017.00071 10.1186/s13195-015-0110-9 10.1016/j.neurobiolaging.2014.06.009 10.1016/j.eplepsyres.2011.01.003 10.1073/pnas.1121081109 10.1016/j.cell.2012.02.046 10.1016/j.eplepsyres.2015.02.005 10.3390/ijms21239318 10.1007/s00415-019-09410-0 10.1523/JNEUROSCI.4002-14.2015 10.1074/jbc.R109.080895 10.1016/j.tins.2008.06.005 10.7554/eLife.22978 10.1111/cns.12144 10.1016/j.pharep.2014.09.013 10.1097/WNR.0000000000000601 10.1016/j.neuropharm.2017.09.031 10.3233/JAD-143162 10.2174/1567205011310040008 10.1016/0197-4580(94)00150-2 10.1177/1535759720905516 10.1016/j.neuron.2008.02.003 10.1038/nn.2801 10.1016/j.celrep.2015.04.017 10.1111/j.1528-1167.2007.01071.x 10.1093/brain/awaa441 10.2165/00002512-200320110-00001 10.1212/WNL.36.9.1226 10.1001/archneur.1990.00530080029006 10.1111/j.1528-1157.1992.tb02343.x 10.1111/j.1528-1167.2006.00554.x 10.1016/j.eplepsyres.2015.05.009 10.1007/s12017-009-8076-z 10.1111/epi.13744 10.1016/j.seizure.2018.07.015 10.1007/s00415-005-0019-5 10.1212/WNL.0000000000003048 10.1093/brain/awl237 10.1212/01.WNL.0000149761.70566.3E 10.1016/j.jns.2007.11.021 10.3233/JAD-2012-111613 10.1016/S1474-4422(16)30193-4 10.1093/brain/awq033 10.3233/JAD-181108 10.1101/cshperspect.a006338 10.1212/WNL.34.7.939 10.1159/000117218 10.1159/000093664 10.1016/j.yebeh.2008.08.012 10.1001/jamaneurol.2013.136 10.3389/fneur.2017.00360 10.3233/JAD-170392 10.1176/appi.neuropsych.15060143 10.1002/ana.24794 10.3233/JAD-160994 10.1093/brain/awy163 10.1093/ije/20.Supplement_2.S36 10.1093/oxfordjournals.aje.a117597 10.1093/oxfordjournals.aje.a114013 10.1212/WNL.40.11.1698 10.1212/WNL.37.10.1630 10.1212/WNL.39.12.1589 10.1212/WNL.41.9.1393 10.18632/aging.202299 10.1212/WNL.0000000000011080 10.1111/j.1528-1167.2006.00884.x 10.1016/j.yebeh.2005.09.004 10.1111/j.0013-9580.2005.02104.x 10.4103/0972-2327.128645 10.1001/jamaneurol.2018.1935 10.1016/j.jns.2018.09.010 10.1111/ane.12260 10.3233/JAD-121750 10.1016/j.jns.2017.08.3742 10.1001/jamaneurol.2016.6091 10.1016/j.eplepsyres.2017.09.006 10.1016/j.jns.2006.11.004 10.1001/archgenpsychiatry.2011.72 10.1212/WNL.0b013e318230a16c 10.1016/j.yebeh.2019.106592 10.1093/neuonc/nos288 10.1016/j.trci.2019.07.012 10.1016/j.yebeh.2010.01.015 10.1016/j.nicl.2015.02.009 10.1016/j.pneurobio.2018.07.003 10.1111/j.1460-9568.2010.07379.x 10.1016/j.eplepsyres.2007.01.002 10.1016/j.yebeh.2016.01.011 10.1371/journal.pone.0174630 10.3233/JAD-150342 10.1038/s41582-019-0205-1 10.1212/WNL.0000000000002683 10.1001/jamaneurol.2019.1424 10.1016/j.neurobiolaging.2017.12.018 10.1007/s00415-018-9100-8 10.1212/WNL.0b013e3181f39a78 10.1016/j.biopsych.2008.02.016 10.1002/mds.26656 10.1136/jnnp.2007.127878 10.1016/S1474-4422(06)70600-7 10.1001/jamanetworkopen.2019.16439 10.3233/JAD-150446 10.1001/archneurol.2011.666 10.1212/WNL.0b013e318245d295 10.1038/s41598-019-47638-y 10.1016/S1474-4422(06)70501-4 10.1073/pnas.1708106114 10.1016/j.nbd.2018.05.020 10.1093/brain/awz381 10.1093/brain/aww187 10.1093/brain/awaa397 10.1523/JNEUROSCI.4152-10.2011 10.1016/j.nbd.2017.08.015 10.1083/jcb.201407065 10.1016/j.nbd.2014.01.007 10.1038/nature07761 10.1016/j.neuron.2013.06.036 10.1038/nn.3178 10.1016/j.yebeh.2019.106861 10.1212/WNL.0000000000009061 10.1177/0333102416683925 10.1111/j.1468-1331.2007.01907.x 10.1111/epi.16068 10.2174/1570159X17666181227165722 10.2165/00023210-200216100-00004 10.1016/S1059-1311(98)80073-3 10.1016/j.yebeh.2018.01.028 10.1111/j.1528-1167.2006.00956.x
Nature Reviews. Neurology; Romoli M, Sen A et. al.

Jun 12th, 2021 - Since the beginning of the Coronavirus Disease-19 (COVID-19) pandemic, Severe Acute Respiratory Syndrome-CoV-2 (SARS-CoV-2) infection has been a serious challenge for immune-compromised patients with immune-mediated inflammatory diseases (IMIDs). ...

see more →

Guidelines  141 results

AGA Clinical Practice Update on Chemoprevention for Colorectal Neoplasia: Expert Review.
https://doi.org/10.1016/j.cgh.2021.02.014
Clinical Gastroenterology and Hepatology : the Official C... Liang PS, Shaukat A et. al.

Feb 13th, 2021 - The purpose of this expert review is to describe the role of medications for the chemoprevention of colorectal neoplasia. Neoplasia is defined as precancerous lesions (e.g., adenoma and sessile serrated lesion) or cancer. The scope of this review ...

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specifi...
https://doi.org/10.1111/jdv.16926
Journal of the European Academy of Dermatology and Venere... Nast A, Smith C et. al.

Feb 6th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Imm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665410
Journal of Crohn's & Colitis; Siegel CA, Christensen B et. al.

Oct 21st, 2020 - Patients with inflammatory bowel diseases [IBD] are frequently treated with immunosuppressant medications. During the coronavirus disease 2019 [COVID-19] pandemic, recommendations for IBD management have included that patients should stay on their...

COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665406
Journal of Crohn's & Colitis; Ng SC, Mak JWY et. al.

Oct 21st, 2020 - Endoscopy is an essential component in the management of inflammatory bowel disease [IBD]. There is a risk of SARS-CoV-2 transmission during endoscopic procedures. The International Organization for the study of IBD [IOIBD] has developed 11 positi...

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Pat...
https://doi.org/10.1053/j.gastro.2020.08.060
Gastroenterology Ananthakrishnan AN, Nguyen GC et. al.

Oct 4th, 2020 - AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review.|2020|Ananthakrishnan AN,Nguyen GC,Bernstein CN,|

see more →

Drugs  55 results see all →

Clinicaltrials.gov  32,877 results

De Novo Inflammatory Bowel Disease Rarely Occurs During Posttransplant Immunosuppression.
https://doi.org/10.1093/ajcp/aqab084
American Journal of Clinical Pathology; Fang JM, Lamps L et. al.

Jun 14th, 2021 - De novo chronic idiopathic inflammatory bowel disease (CIIBD) is reported to occur at higher rates in posttransplant patients than that of the general population. The previous reports, however, included patients with primary sclerosing cholangitis...

Understanding the surgical experience for Black and White patients with inflammatory bo...
https://doi.org/10.1016/j.amjsurg.2021.06.003
American Journal of Surgery; Dos Santos Marques IC, Herbey II et. al.

Jun 13th, 2021 - Racial/ethnic disparities in outcomes exist for patients with inflammatory bowel disease (IBD) undergoing surgery. The underlying mechanism(s) remain unclear and patient perspectives are needed. We therefore aimed to characterize the surgical expe...

Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous cli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692083
Autoimmunity Reviews; Both T, Dalm VASH et. al.

Jun 12th, 2021 - The analysis of time-varying activity and connectivity patterns (i.e., the chronnectome) using resting-state magnetic resonance imaging has become an important part of ongoing neuroscience discussions. The majority of previous work has focused on ...

The Splanchnic Reservoir: An Oasis for Blood Volume in Heart Failure with Preserved Eje...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109966
European Journal of Heart Failure; Patel RB, Shah SJ

Jun 12th, 2021 - Pyoderma gangrenosum is a rare non-infectious skin disorder. It is often associated with systemic diseases, like the inflammatory bowel disease, rheumatological disease and (hematological) malignancy. The diagnosis is affirmed through a process of...

Amyloid-β: a potential link between epilepsy and cognitive decline.
https://doi.org/10.1038/s41582-021-00505-9 10.1016/S1474-4422(18)30256-4 10.1016/S1474-4422(18)30403-4 10.1016/S0140-6736(20)30750-9 10.1016/S1474-4422(16)30356-8 10.1016/S0197-4580(97)00056-0 10.1038/nrdp.2015.56 10.1093/brain/awz268 10.1038/nrneurol.2017.162 10.1016/S1474-4422(12)70291-0 10.1001/jamaneurol.2013.5847 10.1523/JNEUROSCI.5215-08.2009 10.1016/j.neurobiolaging.2016.08.025 10.1001/jamaneurol.2020.0187 10.1038/nrn.2016.141 10.3389/fneur.2020.00199 10.3233/JAD-150544 10.1016/j.neurobiolaging.2018.09.006 10.1016/S0140-6736(19)33064-8 10.3233/JAD-150096 10.1093/brain/awy022 10.1002/ca.980080612 10.1038/nature20814 10.1126/science.1566067 10.1016/j.braindev.2004.07.008 10.1016/S1474-4422(17)30044-3 10.1038/s41583-019-0240-3 10.1001/jamaneurol.2018.0629 10.1038/nn.2583 10.1016/0896-6273(95)90107-8 10.1016/S0896-6273(03)00787-6 10.1523/JNEUROSCI.0277-04.2004 10.1093/hmg/ddh019 10.1016/j.neuron.2007.07.025 10.1001/archneurol.2009.15 10.1186/s13024-017-0231-7 10.1523/JNEUROSCI.5171-13.2014 10.3389/fneur.2019.01151 10.1016/j.neurobiolaging.2018.07.009 10.1126/science.1162844 10.1016/j.brainres.2017.09.026 10.1073/pnas.1206171109 10.1038/nm1782 10.1523/JNEUROSCI.5825-09.2010 10.1101/cshperspect.a024075 10.1093/brain/awv355 10.1038/nn.2433 10.1016/j.neurobiolaging.2006.06.019 10.2174/1567205013666160129095508 10.1016/j.brainres.2010.07.061 10.1126/science.aay0198 10.1146/annurev-neuro-080317-061725 10.3233/JAD-2011-091717 10.1016/j.nbd.2015.10.019 10.1002/hipo.23129 10.1038/nn.2709 10.1038/srep20119 10.1073/pnas.0600948103 10.1101/801902 10.1016/j.neuron.2020.06.005 10.1016/S0896-6273(03)00124-7 10.3892/mmr.2014.1977 10.1126/science.1141736 10.1038/s41593-018-0289-8 10.1038/s41593-020-0687-6 10.1186/s13024-020-00393-5 10.1016/j.neuron.2012.03.023 10.1016/j.yebeh.2019.106478 10.1515/revneuro-2017-0064 10.1016/j.neuroscience.2014.11.051 10.3389/fnagi.2017.00071 10.1186/s13195-015-0110-9 10.1016/j.neurobiolaging.2014.06.009 10.1016/j.eplepsyres.2011.01.003 10.1073/pnas.1121081109 10.1016/j.cell.2012.02.046 10.1016/j.eplepsyres.2015.02.005 10.3390/ijms21239318 10.1007/s00415-019-09410-0 10.1523/JNEUROSCI.4002-14.2015 10.1074/jbc.R109.080895 10.1016/j.tins.2008.06.005 10.7554/eLife.22978 10.1111/cns.12144 10.1016/j.pharep.2014.09.013 10.1097/WNR.0000000000000601 10.1016/j.neuropharm.2017.09.031 10.3233/JAD-143162 10.2174/1567205011310040008 10.1016/0197-4580(94)00150-2 10.1177/1535759720905516 10.1016/j.neuron.2008.02.003 10.1038/nn.2801 10.1016/j.celrep.2015.04.017 10.1111/j.1528-1167.2007.01071.x 10.1093/brain/awaa441 10.2165/00002512-200320110-00001 10.1212/WNL.36.9.1226 10.1001/archneur.1990.00530080029006 10.1111/j.1528-1157.1992.tb02343.x 10.1111/j.1528-1167.2006.00554.x 10.1016/j.eplepsyres.2015.05.009 10.1007/s12017-009-8076-z 10.1111/epi.13744 10.1016/j.seizure.2018.07.015 10.1007/s00415-005-0019-5 10.1212/WNL.0000000000003048 10.1093/brain/awl237 10.1212/01.WNL.0000149761.70566.3E 10.1016/j.jns.2007.11.021 10.3233/JAD-2012-111613 10.1016/S1474-4422(16)30193-4 10.1093/brain/awq033 10.3233/JAD-181108 10.1101/cshperspect.a006338 10.1212/WNL.34.7.939 10.1159/000117218 10.1159/000093664 10.1016/j.yebeh.2008.08.012 10.1001/jamaneurol.2013.136 10.3389/fneur.2017.00360 10.3233/JAD-170392 10.1176/appi.neuropsych.15060143 10.1002/ana.24794 10.3233/JAD-160994 10.1093/brain/awy163 10.1093/ije/20.Supplement_2.S36 10.1093/oxfordjournals.aje.a117597 10.1093/oxfordjournals.aje.a114013 10.1212/WNL.40.11.1698 10.1212/WNL.37.10.1630 10.1212/WNL.39.12.1589 10.1212/WNL.41.9.1393 10.18632/aging.202299 10.1212/WNL.0000000000011080 10.1111/j.1528-1167.2006.00884.x 10.1016/j.yebeh.2005.09.004 10.1111/j.0013-9580.2005.02104.x 10.4103/0972-2327.128645 10.1001/jamaneurol.2018.1935 10.1016/j.jns.2018.09.010 10.1111/ane.12260 10.3233/JAD-121750 10.1016/j.jns.2017.08.3742 10.1001/jamaneurol.2016.6091 10.1016/j.eplepsyres.2017.09.006 10.1016/j.jns.2006.11.004 10.1001/archgenpsychiatry.2011.72 10.1212/WNL.0b013e318230a16c 10.1016/j.yebeh.2019.106592 10.1093/neuonc/nos288 10.1016/j.trci.2019.07.012 10.1016/j.yebeh.2010.01.015 10.1016/j.nicl.2015.02.009 10.1016/j.pneurobio.2018.07.003 10.1111/j.1460-9568.2010.07379.x 10.1016/j.eplepsyres.2007.01.002 10.1016/j.yebeh.2016.01.011 10.1371/journal.pone.0174630 10.3233/JAD-150342 10.1038/s41582-019-0205-1 10.1212/WNL.0000000000002683 10.1001/jamaneurol.2019.1424 10.1016/j.neurobiolaging.2017.12.018 10.1007/s00415-018-9100-8 10.1212/WNL.0b013e3181f39a78 10.1016/j.biopsych.2008.02.016 10.1002/mds.26656 10.1136/jnnp.2007.127878 10.1016/S1474-4422(06)70600-7 10.1001/jamanetworkopen.2019.16439 10.3233/JAD-150446 10.1001/archneurol.2011.666 10.1212/WNL.0b013e318245d295 10.1038/s41598-019-47638-y 10.1016/S1474-4422(06)70501-4 10.1073/pnas.1708106114 10.1016/j.nbd.2018.05.020 10.1093/brain/awz381 10.1093/brain/aww187 10.1093/brain/awaa397 10.1523/JNEUROSCI.4152-10.2011 10.1016/j.nbd.2017.08.015 10.1083/jcb.201407065 10.1016/j.nbd.2014.01.007 10.1038/nature07761 10.1016/j.neuron.2013.06.036 10.1038/nn.3178 10.1016/j.yebeh.2019.106861 10.1212/WNL.0000000000009061 10.1177/0333102416683925 10.1111/j.1468-1331.2007.01907.x 10.1111/epi.16068 10.2174/1570159X17666181227165722 10.2165/00023210-200216100-00004 10.1016/S1059-1311(98)80073-3 10.1016/j.yebeh.2018.01.028 10.1111/j.1528-1167.2006.00956.x
Nature Reviews. Neurology; Romoli M, Sen A et. al.

Jun 12th, 2021 - Since the beginning of the Coronavirus Disease-19 (COVID-19) pandemic, Severe Acute Respiratory Syndrome-CoV-2 (SARS-CoV-2) infection has been a serious challenge for immune-compromised patients with immune-mediated inflammatory diseases (IMIDs). ...

see more →

News  1,767 results

IBD-Related Colon Dysplasia Less Prevalent in Hispanic vs Non-Hispanic White Patients
https://www.medscape.com/viewarticle/952504

Jun 6th, 2021 - (Reuters Health) - The prevalence of colon dysplasia related to inflammatory bowel disease (IBD) appears significantly lower among Hispanic patients than among non-Hispanic whites, even when similar risk factors are present, a new study suggests. ...

Inflammatory Bowel Disease Emergency Management Clinical Practice Guidelines (WSES-AAST, 2021)
https://reference.medscape.com/viewarticle/952268

Jun 2nd, 2021 - Clinical practice guidelines on the management of emergent inflammatory bowel disease by the World Society of Emergency Surgery and the American Association for the Surgery of Trauma were published in May 2021 in the World Journal of Emergency Sur...

Fast Five Quiz: Ankylosing Spondylitis Management
https://reference.medscape.com/viewarticle/932595

May 26th, 2021 - Ankylosing spondylitis (AS) is a recurrent, progressive autoimmune disease that is associated with a high rate of disability. AS is characterized by inflammatory back pain, radiographic sacroiliitis, excess spinal bone formation, and a high preval...

IBD Rates Rising Among Medicare Patients
https://www.medscape.com/viewarticle/951530

May 19th, 2021 - The prevalence of inflammatory bowel disease increased significantly among Americans aged 67 years and older from 2001 to 2018, based on data from more than 25 million Medicare beneficiaries. The worldwide prevalence — or rate of existing cases — ...

IBD Online: What Do Patients Search For?
https://www.medscape.com/viewarticle/951253

May 16th, 2021 - A new online survey of inflammatory bowel disease (IBD) patients found that individuals seeking information on social media are generally satisfied with the care that they get from their health care providers. However, the online activity suggeste...

see more →

Patient Education  53 results see all →